Advisor – Healthcare

Keith Harris, PhD has been an Asset Strategy Leader in Drug Development at AbbVie, since 2020.

Keith has spent his career progressively in research, development, and corporate strategy roles leading teams from early development to proof of concept studies.   From 2010 to 2020, Keith contributed substantially to the development of the Sanofi I&I development portfolio and has guided several early stage projects, both biologics and small molecules.  

Before joining Sanofi I&I development, Keith was project leader and laboratory head in research for 17 years.  Keith is a Ph.D. chemist by training (Universities Warwick, Wisconsin-Madison, Washington-Seattle), a Fellow of the Royal Society of Chemistry, PMP certified, and has an extensive background in pre-clinical and early clinical development.  Throughout his career at Sanofi, Keith has distinguished himself by his passion for his projects, and for his upbeat and positive outlook.